...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: No mention of efficacy again...

Koo, 

What is your point? I never stated that there wasn't a futility analysis for the recently halted aducanumab trials. In fact, I acknowledged this a couple posts ago in this same thread.

BearDownAZ

Share
New Message
Please login to post a reply